Mortality rates are rising from increases in drug overdoses, suicides, and alcohol-related liver disease,
1 yet substance use disorders (SUDs) continue to be underidentified and undertreated.
2-6 The consequences of this unmet need are great, including increased risk of disease, injury, disability and death, and large social and health care costs.
7-10 Opioid and alcohol use disorders (OAUD) are of particular concern owing to their high rates of morbidity and mortality
11-14 and the increasing prevalence of prescription opioid misuse.
15 Research supports the effectiveness of treatment for OAUD
16-20 but few individuals receive treatment. Addressing this need has numerous potential benefits.
21